ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Configurability And Customization: Key Features In An eTMF Solution
Discover how a configurable and customizable eTMF can lend itself to better information control during a clinical trial while boosting security and regulatory compliance efforts.
-
Empowering Oncology Research With The Right Technology Solutions
Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
How Electronic Source Data Revolutionizes Clinical Research
By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.
-
The Impact Of RWD And Cloud Tech On Research, Health Outcomes
Far too often, valuable data sources are siloed, disparate, and unusable. Learn how expansive datasets can empower the industry to advance clinical trials and outcomes research, benefiting all communities.
-
A Few Clicks And Done: Automating EDC Data Entry
A novel solution has emerged to tackle the inefficiency and errors in manual data re-entry during clinical trials, streamlining data entry, eliminate application switching, and benefit all stakeholders.
-
The Impact Of Clinical Trial Payments On Site-Sponsor Relationships
The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
Managing Risk And Regulation In Clinical Trial Technology
Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.
-
EDC For Mid-Study Changes In Medical Device Clinical Trials
In this case study, discover how a company was pointed to an electronic data capture (EDC) system that was quick to adapt and easy to scale as the study changed.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up